» Articles » PMID: 34911614

Protective Effect of Adrenomedullin on Hyperoxia-induced Lung Injury

Overview
Specialty Pediatrics
Date 2021 Dec 16
PMID 34911614
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To study the role of adrenomedullin (ADM) in hyperoxia-induced lung injury by examining the effect of ADM on the expression of calcitonin receptor-like receptor (CRLR), receptor activity-modifying protein 2 (RAMP2), extracellular signal-regulated kinase (ERK), and protein kinase B (PKB) in human pulmonary microvascular endothelial cells (HPMECs) under different experimental conditions.

Methods: HPMECs were randomly divided into an air group and a hyperoxia group (=3 each).The HPMECs in the hyperoxia group were cultured in an atmosphere of 92% O (3 L/minute) +5% CO. RT-qPCR and Western blot were used to measure the mRNA and protein expression levels of ADM, CRLR, RAMP2, ERK1/2, and PKB. Other HPMECs were divided into a non-interference group and an interference group (=3 each), and the mRNA and protein expression levels of ADM, ERK1/2, and PKB were measured after the HPMECs in the interference group were transfected with ADM siRNA.

Results: Compared with the air group, the hyperoxia group had significant increases in the mRNA and protein expression levels of ADM, CRLR, RAMP2, ERK1/2, and PKB (<0.05). Compared with the non-interference group, the interference group had significant reductions in the mRNA and protein expression levels of ADM, ERK1/2, and PKB (<0.05).

Conclusions: ERK1/2 and PKB may be the downstream targets of the ADM signaling pathway. ADM mediates the ERK/PKB signaling pathway by regulating CRLR/RAMP2 and participates in the protection of hyperoxia-induced lung injury.

Citing Articles

Single-cell transcriptomic characterization reveals the landscape of airway remodeling and inflammation in a cynomolgus monkey model of asthma.

Wang Y, Dong X, Pan C, Zhu C, Qi H, Wang Y Front Immunol. 2022; 13:1040442.

PMID: 36439114 PMC: 9685410. DOI: 10.3389/fimmu.2022.1040442.

References
1.
Menon R, Shrestha A, Reynolds C, Barrios R, Caron K, Shivanna B . Adrenomedullin Is Necessary to Resolve Hyperoxia-Induced Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension in Mice. Am J Pathol. 2020; 190(3):711-722. PMC: 7074343. DOI: 10.1016/j.ajpath.2019.11.011. View

2.
Gao Y, Li J, Qiao N, Meng Q, Zhang M, Wang X . Adrenomedullin blockade suppresses sunitinib-resistant renal cell carcinoma growth by targeting the ERK/MAPK pathway. Oncotarget. 2016; 7(39):63374-63387. PMC: 5325371. DOI: 10.18632/oncotarget.11463. View

3.
Jobe A . The new BPD: an arrest of lung development. Pediatr Res. 1999; 46(6):641-3. DOI: 10.1203/00006450-199912000-00007. View

4.
Zhang S, Patel A, Moorthy B, Shivanna B . Adrenomedullin deficiency potentiates hyperoxic injury in fetal human pulmonary microvascular endothelial cells. Biochem Biophys Res Commun. 2015; 464(4):1048-1053. PMC: 4558361. DOI: 10.1016/j.bbrc.2015.07.067. View

5.
Kim W, Moon S, Sung M, Kim S, Lee S, So J . Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J. 2003; 17(13):1937-9. DOI: 10.1096/fj.02-1209fje. View